FR2709753B1 - Nitrates organiques, leur procédé de préparation et leur application comme médicaments. - Google Patents

Nitrates organiques, leur procédé de préparation et leur application comme médicaments.

Info

Publication number
FR2709753B1
FR2709753B1 FR9310714A FR9310714A FR2709753B1 FR 2709753 B1 FR2709753 B1 FR 2709753B1 FR 9310714 A FR9310714 A FR 9310714A FR 9310714 A FR9310714 A FR 9310714A FR 2709753 B1 FR2709753 B1 FR 2709753B1
Authority
FR
France
Prior art keywords
medicaments
preparation
organic nitrates
nitrates
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9310714A
Other languages
English (en)
Other versions
FR2709753A1 (fr
Inventor
Jean-Marie Ruxer
Alain Berdeaux
Marie-Luce Bea
Vincent Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst SA filed Critical Laboratoires Hoechst SA
Priority to FR9310714A priority Critical patent/FR2709753B1/fr
Publication of FR2709753A1 publication Critical patent/FR2709753A1/fr
Application granted granted Critical
Publication of FR2709753B1 publication Critical patent/FR2709753B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9310714A 1993-09-09 1993-09-09 Nitrates organiques, leur procédé de préparation et leur application comme médicaments. Expired - Fee Related FR2709753B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9310714A FR2709753B1 (fr) 1993-09-09 1993-09-09 Nitrates organiques, leur procédé de préparation et leur application comme médicaments.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9310714A FR2709753B1 (fr) 1993-09-09 1993-09-09 Nitrates organiques, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
FR2709753A1 FR2709753A1 (fr) 1995-03-17
FR2709753B1 true FR2709753B1 (fr) 1995-12-01

Family

ID=9450685

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9310714A Expired - Fee Related FR2709753B1 (fr) 1993-09-09 1993-09-09 Nitrates organiques, leur procédé de préparation et leur application comme médicaments.

Country Status (1)

Country Link
FR (1) FR2709753B1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CN102453001B (zh) * 2010-10-22 2016-06-01 中国医学科学院药物研究所 硫代吗啉类化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836021A1 (de) * 1988-10-22 1990-05-03 Boehringer Mannheim Gmbh Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen
DE4004841A1 (de) * 1990-02-16 1991-08-22 Boehringer Mannheim Gmbh Salpetersaeureester von cyclohexanol-derivaten

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors

Also Published As

Publication number Publication date
FR2709753A1 (fr) 1995-03-17

Similar Documents

Publication Publication Date Title
DZ1869A1 (fr) Nouveaux dérivés de lérythromycine, leur procédé de préparation et leur application comme médicaments.
DZ1878A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
OA09432A (fr) N-aryl-azétidinones, leur procédé de préparation et leur utilisation comme inhibiteurs des élastases.
FR2678615B1 (fr) Benzofuranne-2-ones thiomethylees, leur preparation et leur application comme stabilisants de matieres organiques.
DZ2702A1 (fr) Nouveaux amides aromatiques leur procédé de préparation et leur application comme médicaments.
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
FR2715402B1 (fr) Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2696744B1 (fr) Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2692579B1 (fr) Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2709753B1 (fr) Nitrates organiques, leur procédé de préparation et leur application comme médicaments.
FR2704773B1 (fr) Procédé de préparation de catalyseurs utilisables en déshydrogénation.
FR2693202B1 (fr) Polymères amphiphiles hydrosolubles, leur procédé de préparation et leur application comme épaississant.
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
FR2702481B1 (fr) Nouveaux récepteurs Fc-gamma III humains solubles, leur procédé de préparation, les compositions pharmaceutiques les contenant, leur application comme médicaments et leur application diagnostique.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2693197B1 (fr) Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2700336B1 (fr) Succinimides substituées, leur procédé de préparation et leur application comme inhibiteur de corrosion.
FR2710065B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2707986B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2711137B1 (fr) Allylaminoesters, leur procédé de préparation et leur application en thérapeutique.
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse